Fintech company Pine Labs has approved a grant of 16,37,152 employee stock options (ESOPs) to its eligible workforce. The decision, taken by the company's Nomination and Remuneration Committee on 28 October 2026, falls under the Employee Stock Option Plan 2025 and is well within the shareholder-approved limit of over 10 crore stock options.
The options will be granted to eligible employees, with vesting scheduled to commence 12 months from the grant date. They are convertible into fully paid-up equity shares, each with a face value of ₹1. The grant comprises various tranches with different exercise prices, including 11,63,937 ESOPs at ₹139.94, 2,36,370 ESOPs at ₹150.06 and 2,36,845 ESOPs at ₹5.40, with pricing based on the volume-adjusted weighted average price of the preceding three months, with a 10% discount applied except for the ₹5.40 tranche.
ESOP grants of this size are a retention signal as much as a compensation tool. For a company of Pine Labs' scale, a broad-based grant tells employees that their wealth is tied to the company's future value — and tells the market that the company is investing in keeping its team through its next phase.
For founders, the structure is worth studying: a 12-month vesting start, tranched pricing and a shareholder-approved pool large enough to avoid returning for approval every year. ESOP design is often treated as paperwork; in practice, it is one of the most consequential retention decisions a growing company makes.
Pine Labs' move comes in a week when several large Indian internet companies reported earnings and refreshed their talent plans — a reminder that in a competitive hiring market, equity remains the currency that keeps senior teams in place.
Why it matters for founders
Treat your ESOP pool as strategy, not admin. A well-designed plan — clear vesting, fair pricing, a pool sized for years — retains the people who build the company, and it costs nothing until the value they create actually exists.